Qiagen's Q2 Revenues Increase 10 Percent; Beats Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen reported after the close of the market Monday that its second-quarter revenues increased 10 percent and its profit rose 33 percent, beating analysts' consensus estimates for both the top and bottom lines.

The molecular diagnostics and life sciences products firm brought in total revenues of $240.2 million compared to $217.9 million for the second quarter of 2008. Analysts, on average, had expected revenues of $232 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.